Precision oncology and evidence platform
GeneSilico offers a cutting-edge Precision Oncology Platform, integrating a cloud-based multi-omics data lake and advanced AI analytics. This unified environment enables real-time genomic data analysis, supporting oncologists and researchers in making precise diagnoses and treatment decisions for breast cancer patients at any stage.
Beyond Predictions: Actionable Insights
Harnessing the vast potential of machine learning and artificial intelligence, we delve deep into genetic data and cellular behaviors. Our software can simulate therapy responses, including potentially resistant therapies, and recommend alternative treatment pathways.
Comprehensive Genomic Profiling
At the core of our technology lies our advanced genomic sequencing tools. These tools can identify the minutest mutations, which often hold the key to effective treatment strategies. By decoding the tumor’s genomic profile, we ensure that a deep understanding of the unique cancer diagnosis backs every therapy option.
Real-World Simulations
Through our intricate biological models, we can simulate how different therapies might impact individual cancer profiles. This marriage of biology and digital technology helps refine our recommendations, ensuring they’re accurate and actionable.
Personalized treatment options with generative AI in minutes
Match the best-fit first, second, and third-line FDA-approved therapies and clinical trials for invasive cancer based on real-world evidence. Patients will have access to a tumor board with no limits.
